ZBiotics

Private

San Francisco, CaliforniaHealthcare & Life Scienceshttps://zbiotics.com/

Last Round

Series A

Aug 27, 2024

Est. Valuation

$1.71M

Total Funding Raised

$17.7M

Company Overview

ZBiotics is a biotechnology company that develops genetically engineered probiotics designed to improve human health by addressing everyday biological challenges, such as breaking down alcohol byproducts.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, D2C Brands, E-commerce

Business Model

B2C

Customer Profile

Hardware Sales, Subscription SaaS

AI Layer

Application

Keywords

synthetic biologygenetically engineered probiotichangover curepre-alcohol probioticfunctional beverageDTCdirect-to-consumergut healthbioengineered bacteriaacetaldehyde breakdownhangover preventionsynbioprobiotic supplementconsumer healthsubscription supplement

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

ZBiotics Comps

Public and private peers based on sector, stage, and business model.

ZBiotics comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

ZBiotics Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Series A	Aug 27, 2024
Seed	Mar 12, 2020
Accelerator	Aug 7, 2018
Seed	Mar 21, 2018

View all Funding Rounds

Key People

Founding team and executive leadership

Zachary Abbott

Founder, CEO

Founding Team

ZBiotics Investors

Notable investors and investment history

ZBiotics investors
Investor	Rounds
Utopian Ventures	Seed
Oyster Ventures	Seed
Access Capital	Series A
Seamless Capital	Series A
BABEL Ventures	Seed
Babel Ventures	Seed
Seamless Capital	Series A

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Aug 28, 2024
$12M round completed.
Jan 1, 2024
Sugar-to-Fiber, a probiotic drink mix, is launching in 2024.

View all signals

ZBiotics Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

ZBiotics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about ZBiotics's valuation, stock price, and market status.

Firmographic Details

HeadquartersSan Francisco, California

Employee Range62

Year Founded2016

Last FundingAug 27, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.